Noticias de Eulerpool Astellas Pharma

Astellas Pharma Noticias de Acciones

Astellas Pharma es observado por muchos periodistas e inversores en todo el mundo. Aquí recopilamos las noticias más recientes de Astellas Pharma.

• 3 de junio ·

  Yahoo
  How leading oncology drugmakers set the stage for future advances
• 30 de mayo ·

  Yahoo
  Astellas and Evopoint sign ADC licensing deal
• 30 de mayo ·

  Yahoo
  Keros lays off nearly half its staff; Astellas buys into a China biotech’s ADC
• 30 de mayo ·

  Yahoo
  Astellas Enters Exclusive License Agreement with Evopoint Biosciences for XNW27011, a Novel Clinical-stage Antibody-Drug Conjugate Targeting CLDN18.2
• 28 de mayo ·

  Yahoo
  Astellas Announces Second Annual Patient Advocacy Organization (PAO) Action Week™ To Empower Patients and Caregivers
• 27 de mayo ·

  SeekingAlpha
  Merck Proves Why It's Still A Top Pharma Pick
• 27 de mayo ·

  Yahoo
  Is Astellas Pharma (ALPMY) Stock Outpacing Its Medical Peers This Year?
• 22 de mayo ·

  Yahoo
  Astellas and Pfizer's XTANDI™ (enzalutamide) Shows Long-Term Overall Survival in Metastatic Hormone-Sensitive Prostate Cancer
• 21 de mayo ·

  Yahoo
  Astellas and MBC BioLabs Announce the 2025 Astellas Future Innovator Prize Awarded to DeepSeq.AI & Serna Bio
• 19 de mayo ·

  Yahoo
  Astellas Presents New Data that Explores Potential of its Cancer Therapies at 2025 ASCO Annual Meeting